The findings suggest that use of the pacing technique during CRT should be reserved for expert operators, at least for now.
Early data from the first phase III trial of Lilly’s triple agonist show reductions in weight and HbA1c for patients with ...
The 15-year data help support the idea that each test can aid in putting the other’s results in perspective, but questions ...
Ami Bhatt discusses the effort to build an infrastructure and guardrails for AI and how clinicians can take part.
The study of LAAO cases provides physicians with evidence they can cite when requesting tools for additional protection.
Women had better self-care at 5 years with self-expanding valves, raising questions about lower gradients and stroke impacts.
Diastolic BP was higher years after giving birth for women who reported stress—but only if they’d had a complicated pregnancy ...
The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be superior.
Both CV mortality and major bleeding were rarer when antiplatelets weren’t added, with no tradeoff in ischemic events.
The vast majority of patients presenting with type 1 NSTEMI undergo invasive coronary angiography in the US, with most ...
For primary prevention patients at high risk, such as those with a 10-year risk > 10%, the LDL target is less than 70 mg/dL (class 2a recommendation). For this group, treatment begins with a ...
Final follow-up from the trial shows durable protection against TLF, especially in chronic total occlusions and diffuse long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results